TARGIN® Prolonged Release Tablets 10mg/5mg
Product details
Registration number: SIN14032P
Classification: Prescription Only
Active ingredients:
- Naloxone 4.50mg eqv to Naloxone Hydrochloride Anhydrous
- Oxycodone 9.00mg eqv Oxycodone Hydrochloride Anhydrous
Strength:
- 5 mg
- 10 mg
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Registrant: DKSH SINGAPORE PTE. LTD.
ATC code: N02AA55
HSA approval date: 19 October 2011
Manufacturer(s): Bard Pharmaceuticals Limited
Manufacturing country/countries: UNITED KINGDOM
What are the HSA registration number and classification for TARGIN® Prolonged Release Tablets 10mg/5mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14032P
Classification: Prescription Only
What active ingredients and strength are recorded for TARGIN® Prolonged Release Tablets 10mg/5mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Naloxone 4.50mg eqv to Naloxone Hydrochloride Anhydrous
- Oxycodone 9.00mg eqv Oxycodone Hydrochloride Anhydrous
Strength:
- 5 mg
- 10 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for TARGIN® Prolonged Release Tablets 10mg/5mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Who is the recorded registrant for TARGIN® Prolonged Release Tablets 10mg/5mg?
According to the HSA dataset updated 7 August 2026:
Registrant: DKSH SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for TARGIN® Prolonged Release Tablets 10mg/5mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Bard Pharmaceuticals Limited
Manufacturing country/countries: UNITED KINGDOM
Where can I look up TARGIN® Prolonged Release Tablets 10mg/5mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14032P or the exact product name TARGIN® Prolonged Release Tablets 10mg/5mg. The general register link does not preselect this product.
What are the source dates for this TARGIN® Prolonged Release Tablets 10mg/5mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this TARGIN® Prolonged Release Tablets 10mg/5mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14032P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)